BELMONT, Calif.--(BUSINESS WIRE)--LakePharma, Inc. the leading protein engineering CRO dedicated to providing integrated biologics discovery and development services, will present key data at the upcoming PEGS 2016 Protein Engineering Summit in the form of several case studies highlighting the challenges that arise from the multiple domain nature of fusion protein therapeutics. Specifically, Hua Tu, Ph.D., LakePharma’s Chairman and CEO, will share data for the design, engineering, bioanalytical characterization and manufacturability assessment of Fc fusions and bispecific antibodies.
